This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Find out what to do with your credit card points. Learn how to redeem for rewards and make the most of your points.
14,952 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A top strategist warns that investor fear could surge as U.S.-Iran tensions persist, with markets facing heightened v...
OCBC unveils an AI-driven avatar banking platform featuring two virtual advisors, Wendy and Wayne. The bank says the ...
A new wave of policy proposals seeks to curb large landlords by banning institutional investors from buying single-fa...
Analysts expect a stronger cost-of-living adjustment in 2027, potentially lifting the average Social Security check b...
U.S. stock futures dip as oil prices rise amid renewed Iran tensions. Traders brace for energy-driven volatility and ...
Bitcoin rebounds to $60,000 as softer data calms rate-hike fears. This guide breaks down what moved prices, who’s buy...
Tokenized stocks are moving from concept to reality as major exchanges edge toward on-chain equity trading. This repo...
Today’s market moves show a tech-led rotation and Meta’s cloud pivot stealing the spotlight. Here’s what it means for...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
President Trump disclosed a $2.2 billion 2025 income, including roughly $1 billion from crypto. Washington’s ethics e...
The March NAHB/Wells Fargo HMI shows homebuilder confidence nudges remains at 38, signaling a tepid market as incenti...